Aurora Cannabis Reports 2Q Results, Global Medical Cannabis Revenues Up

Aurora Cannabis Inc. ACB ACB, reported its financial and operational results late Thursday for the fiscal second quarter that ended December 31, 2022.

"Following a tremendous effort to realize approximately $340 million of total annualized savings since February 2020, (...) we have right-sized our business while remaining the #1 Canadian LP in global medical cannabis revenues, and having demonstrated organic quarter-over-quarter revenue growth across all of our cannabis segments during Q2 2023,” said Miguel Martin, CEO of Aurora.

"Our Canadian rec business also demonstrated sequential growth driven by significant product innovation (...) Q2 2023 also included the first full quarter of results from our recent Bevo Agtech Inc. acquisition, for which we anticipate an even higher top-line and Adjusted EBITDA contribution in Q3 2023 versus Q2 2023 due to the inherent seasonality of this business."


  • Cannabis Revenues Up ~20% from Fiscal Q1 2023, Net Revenue of $61.7 Million
  • Achieving Positive Adjusted EBITDA in Line with Prior Guidance
  • Delivering ~$340 Million in Annualized Cost Savings Since February 2020
  • Balance Sheet Remains in net cash position, “among strongest in the industry,” per a company release.
  • Debt Reduction of ~$302 Million in CY 2022

Medical Cannabis

Aurora reported that medical cannabis net revenue was $39.5 million, a 25% increase from the prior quarter and a 14% decrease from the prior year period, delivering 64% of Aurora's Q2 2023 consolidated net revenue and 87% of Adjusted gross profit before fair value adjustments. “The increase in net revenue from Q1 2023 was primarily attributable to growth into international export markets such as Australia, Poland, and the UK,” reported the firm.

Price Action 

At market close on Thursday, Aurora's shares were trading lower by 6.18%, at $0.92 per share. 

Image Credits: geralt and Kindel Media by Pixabay. 

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsPenny StocksMarketsAurora CannabisMiguel Martin
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on – Prices will increase very soon!